Further, young women’s ER+ breast cancers have threefold increased likelihood of progressing to metastatic disease when diagnosed postpartum (PPBC) compared with nulliparous cases (Nulliparous Breast Cancer–NPBC)34. Here, ESR1 is linked to metastatic neoplasm.